Reports

Orix Corporation reported a 5.4% increase in total revenue, reaching ¥2,154,484 million. Operating income rose by 9.3% to ¥290,724 million, while net income attributable to shareholders surged 24% to ¥271,777 million. Earnings per share saw a significant jump, reflecting the company's strong financial performance for the quarter.

• Total revenue increased 5.4% year-on-year to ¥2,154,484 million.
• Net income attributable to shareholders rose 24% to ¥271,777 million.

Compass Minerals reported revenue of $307.2 million for Q1 FY25, a 10% decline from the prior year. Net loss stood at $23.6 million, an improvement over the $75.3 million loss in Q1 FY24. The Salt segment saw a 12% revenue decline due to lower deicing salt sales, while Plant Nutrition revenue increased 24% on higher sales volumes. Adjusted EBITDA fell to $32.1 million from $62.2 million, reflecting ongoing pricing challenges and operational costs.

• Revenue declined 10% year over year to $307.2 million.
• Salt segment revenue dropped 12% due to lower deicing salt sales.

Roivant Sciences saw a revenue decline of 42% year-over-year, driven by lower collaboration revenue. The company reported a net income of $118.1 million, significantly lower than the previous year's $5.07 billion due to a one-time gain from the Telavant sale in the prior year. Operating expenses rose due to higher R&D investments, particularly in its anti-FcRn franchise. Despite the losses, Roivant maintains a strong liquidity position with $5.2 billion in cash and marketable securities.

• Revenue declined by 42% year-over-year to $9.0 million.
• Net income was $118.1 million, down from $5.07 billion YoY due to the prior year's one-time gain.

Prospect Capital reported a decline in net investment income and NAV per share, with total investment income down 12.1% YoY. Despite net losses, the company maintained stable distributions to shareholders.

• Net Investment Income (NII) per share declined 16.7% YoY to $0.20.
• Total investment income decreased 12.1% YoY to $185,466,000.

Arrowhead Pharmaceuticals reported a net loss of $173.085 million for the fiscal first quarter ended December 31, 2024, with total revenue of $2.5 million. The company emphasized its strategic achievements, including a major licensing deal with Sarepta Therapeutics worth up to $10 billion in potential milestones and the FDA's acceptance of its plozasiran NDA, positioning it for future growth and potential commercial launches.

• Arrowhead signed and closed a licensing and collaboration agreement with Sarepta Therapeutics, receiving $825 million upfront ($500 million cash, $325 million equity investment) and eligibility for up to $10 billion in potential milestone payments.
• The U.S. FDA accepted the New Drug Application (NDA) for investigational plozasiran for familial chylomicronemia syndrome, with a PDUFA action date of November 18, 2025.

CoreCivic concluded 2024 with robust financial performance, achieving a total revenue of $479.3 million and a net income of $19.3 million for the fourth quarter. The company's occupancy rate reached 75.5%, the highest since Q1 2020, despite contract terminations with ICE and CDCR. CoreCivic also provided optimistic full-year 2025 guidance, anticipating accelerated demand from government partners and leveraging its available capacity and strong balance sheet.

• Total revenue for Q4 2024 was $479.3 million, with a net income of $19.3 million.
• Diluted earnings per share were $0.17, and Adjusted Diluted EPS was $0.16.

Axcelis Technologies, Inc. concluded 2024 with strong fourth-quarter results, exceeding expectations in revenue and profitability. Despite a full-year revenue decline compared to 2023, the company achieved higher gross margins and generated solid free cash flow, positioning itself for future growth amidst a cyclical digestion period.

• Fourth quarter revenue was $252.4 million, exceeding expectations.
• Diluted earnings per share for Q4 2024 was $1.54.

Fluence Energy, Inc. announced its first fiscal quarter 2025 results with revenue of $186.8 million, a 49% decrease year-over-year, primarily due to the backend-loaded nature of expected revenue for fiscal year 2025. Despite the revenue decline, GAAP gross profit margin improved to 11.4% from 10.0% in the prior year. The company reported a net loss of $57.0 million and a record backlog of $5.1 billion.

• Revenue for Q1 2025 was approximately $186.8 million, a decrease of 49% compared to the same quarter last year, attributed to the backend-loaded revenue recognition for fiscal year 2025.
• GAAP gross profit margin improved to 11.4% in Q1 2025, up from 10.0% in the same quarter last year, with Adjusted gross profit margin reaching 12.5%.

Danaos Corporation's Q4 2024 results show a mixed performance with operating revenues increasing by 3.6% to $258.2 million, but net income decreasing to $90.4 million from $149.9 million in Q4 2023. Diluted EPS also fell to $4.70 from $7.70 in the prior year period. The decrease in net income was primarily due to increased operating expenses and a significant loss on marketable securities, partially offset by higher operating revenues.

• Operating revenues increased by 3.6% to $258.2 million in Q4 2024, driven by additions of dry bulk vessels to the fleet.
• Net income decreased significantly to $90.4 million in Q4 2024 from $149.9 million in Q4 2023, primarily due to a $35.6 million loss on marketable securities.

Harmonic achieved record quarterly total company revenue and Adjusted EBITDA, with both Broadband and Video revenue exceeding expectations. The company's strong performance in Broadband demonstrates its ability to scale to customer needs and its technology leadership, positioning it well for long-term growth in broadband DOCSIS 4.0 and Fiber.

• Record total quarterly revenue of $222.2 million, up 33% year over year.
• Record quarterly Adjusted EBITDA of $71.8 million, significantly up from $21.7 million in the prior year period.

Universal Corporation achieved solid results for the third quarter of fiscal year 2025, with strong performance in its Tobacco Operations segment due to robust customer demand and successful procurement efforts, while the Ingredients Operations segment performed in line with strategic plans with new product sales offsetting pricing pressures.

• Universal Corporation reported total sales and other operating revenue of $937.2 million for the third quarter of fiscal year 2025.
• Net income attributable to Universal Corporation was $57.1 million, resulting in basic earnings per share of $2.28 and diluted earnings per share of $2.27.

Apollo Commercial Real Estate Finance, Inc. reported a net income of $0.27 per diluted share and distributable earnings of $0.32 per diluted share for the fourth quarter of 2024. The company saw significant capital deployment, with $2.5 billion in repayments and successful redeployment into new, attractively priced loans.

• Net income per diluted share for Q4 2024 was $0.27.
• Distributable Earnings per diluted share for Q4 2024 was $0.32.

Columbus McKinnon's Q3 FY25 results showed a decline in net sales and profitability, primarily due to slowing industry demand, delayed customer decision-making, and unfavorable foreign currency movements. Despite these challenges, the company continued its debt repayment and footprint simplification initiatives.

• Net sales decreased by 7.9% to $234.1 million, driven by lower volume and unfavorable foreign currency translation.
• GAAP EPS was $0.14, a significant decrease from $0.34 in the prior year, impacted by unfavorable FX movements.

SelectQuote, Inc. reported consolidated revenue for the second quarter of fiscal year 2025 of $481.1 million, compared to $405.4 million for the second quarter of fiscal year 2024. Consolidated net income for the second quarter of fiscal year 2025 was $53.2 million, compared to $19.4 million for the second quarter of fiscal year 2024. Consolidated Adjusted EBITDA was $87.5 million compared to $67.4 million for the second quarter of fiscal year 2024.

• SelectQuote delivered impressive results during the fiscal second quarter.
• Strong policy volume and Senior Adjusted EBITDA margin of 39%, up approximately 750 basis points year-over-year.

GCM Grosvenor reported its fourth quarter and full year results for the period ending December 31, 2024, showcasing a 41% increase in 2024 fundraising and significant growth in year-to-date GAAP net income, fee-related earnings, and adjusted net income.

• GCM Grosvenor reported Q4 and full year 2024 earnings.
• 2024 fundraising increased by 41%.

Compass Minerals reported a net loss of $23.6 million and diluted EPS of -$0.57 for the first quarter of fiscal 2025. Revenue totaled $307.2 million. The company saw a decline in salt inventory volumes year over year despite a slow start to the winter deicing season, and made progress in improving the cost structure of its Plant Nutrition business.

• North American salt inventory volumes declined 10% year over year through December.
• Salt revenue decreased 12% year over year, driven by a 13% sales volume decline, partially offset by a 1% increase in average sales price.

RCI Hospitality Holdings, Inc. experienced a slight decrease in total revenues by 3.3% to $71.483 million compared to the prior year, primarily due to closed locations. However, the company saw a significant increase in net income by 24.9% to $9.024 million and operating income by 5.6% to $13.906 million. Diluted EPS also rose to $1.01 from $0.77 in the comparable prior-year quarter.

• Total revenues decreased by 3.3% to $71.483 million, primarily due to the impact of closed locations, partially offset by new locations and same-store sales growth.
• Net income attributable to RCIHH common stockholders increased by 24.9% to $9.024 million.

PennantPark Floating Rate Capital Ltd. reported a net investment income of $30.0 million and a net increase in net assets resulting from operations of $28.3 million for the first quarter ended December 31, 2024. The company's investment portfolio grew to $2,193.9 million, and it maintained a strong weighted average yield on debt investments of 10.6%.

• Net investment income increased to $30.0 million, up from $19.4 million in the prior year, driven by an increase in investment income partially offset by higher expenses.
• The investment portfolio expanded to $2,193.9 million, primarily consisting of first lien secured debt, reflecting active investment in new core middle market loans.

Hain Celestial reported a decrease in net sales and a net loss for Q2 2025. Despite these challenges, the company generated strong operating cash flow and reduced its debt. The company is exploring strategic options for its personal care business.

• Net sales decreased by 9% year-over-year to $411 million.
• Organic net sales decreased by 7% compared to the prior year period.

PennantPark Investment Corporation reported a net investment income of $13.0 million, or $0.20 per share, for the first quarter ended December 31, 2024. The company's total investment income was $34.2 million, with a net increase in net assets resulting from operations of $16.1 million.

• Net investment income for the quarter was $13.0 million, a decrease from $15.7 million in the prior year.
• Total investment income was $34.2 million, slightly down from $34.3 million in the same period last year.

Mitek reported relatively flat revenue year-over-year at $37.3 million, with SaaS products growing 29%. The company's GAAP net loss was $4.6 million, improved from a $5.8 million loss the previous year. Mitek raised the lower end of its Adjusted EBITDA margin guidance range for fiscal 2025.

• Revenue was $37.3 million, relatively flat year-over-year.
• GAAP net loss was $4.6 million, compared to a GAAP net loss of $5.8 million a year ago.

Radiant Logistics reported revenues of $264.5 million and net income of $6.5 million for the second fiscal quarter ended December 31, 2024. The company's adjusted EBITDA was $12.0 million, and they continue to focus on profitable growth through organic and acquisition initiatives.

• Revenues increased by 31.5% to $264.5 million compared to the prior year period.
• Net income attributable to Radiant Logistics, Inc. increased by 550.0% to $6.5 million, or $0.13 per fully diluted share.

EVI Industries reported record revenue of $93 million and record gross profit of $28 million for the second quarter ended December 31, 2024. The company's investments in sales and service teams and technology initiatives impacted operating profits but are expected to yield positive returns in the future. The company also completed two acquisitions during the six-month period ended December 31, 2024

• Record revenue of approximately $93 million for the three-month period ended December 31, 2024, an increase of 1% compared to the same period of the prior fiscal year.
• Set second quarter record for gross profit at $28 million.

RGC Resources reported first quarter earnings of $5,269,689, or $0.51 per share, compared to $5,019,992, or $0.50 per share, for the same quarter last year. The increase was driven by higher utility margin from new base rates and colder weather, but offset by lower equity earnings from unconsolidated affiliate and higher interest expense.

• Earnings per share increased to $0.51 from $0.50 in the prior year.
• Utility margin increased due to new base rates that went into effect July 1, 2024.

CSPi's fiscal 2025 first quarter showed positive momentum with a 2% increase in total revenue to $15.7 million and a 17% increase in services revenue. The company expanded its gross margin and reported a net income of $0.05 per diluted common share.

• Services revenue increased by 17% driven by cloud-based and recurring revenue sources.
• Signed several new ARIA Zero Trust Protect (AZT PROTECT™) customers.

Motorcar Parts of America reported record fiscal third quarter results, with net sales increasing by 8.3% to $186.2 million and gross profit increasing by 49.4% to $44.9 million. The company generated $34.4 million in cash from operating activities and reduced net bank debt by $30.3 million.

• Net sales increased 8.3 percent to a fiscal third quarter record $186.2 million.
• Gross profit increased 49.4 percent to a record $44.9 million.

Enanta Pharmaceuticals reported a net loss of $22.3 million for the fiscal first quarter ended December 31, 2024, with total revenue of $17.0 million, primarily from MAVYRET®/MAVIRET® royalties. The company is on track with its RSV and immunology programs, with key data readouts and development candidate selections expected in 2025.

• Total revenue for the quarter was $17.0 million, a decrease from $18.0 million in the same period last year.
• The company reported a net loss of $22.3 million, or $1.05 per diluted common share, an improvement from a net loss of $33.4 million in the prior year.

PetMed Express reported third-quarter results with net sales of $53.0 million. The company achieved an adjusted EBITDA of $2.0 million, a $1.1 million improvement year-over-year, while reducing G&A expenses by $2.6 million compared to last year. The gross margin rate increased by 80 basis points compared to the prior year period.

• Net sales reached $53.0 million.
• Gross margin rate increased by 80 basis points compared to the prior year period, reaching 28.1%.

iBio reported revenue of $0.2 million for services provided to a collaborative partner and a net loss of $4.4 million, or $0.48 per share, for the second quarter ended Dec. 31, 2024. The company also highlighted advancements in its preclinical pipeline and key board appointments.

• Discovered a novel antibody targeting activin E in collaboration with AstralBio.
• Expanded iBio’s cardiometabolic and obesity program with IBIO-600, the long-acting anti-myostatin antibody in-licensed from AstralBio.